I am a
Home I AM A Search Login

Papers of the Week

Papers: 8 Jun 2024 - 14 Jun 2024

2024 Jun 05

CNS Neurol Disord Drug Targets


Safety and Efficacy of Calcitonin Gene-related Peptide Receptor Antagonists and Selective Serotonin Receptor Agonist in the Management of Migraine: A Systematic Review and Meta-analysis.


Singh P, Ponnada RK, Sharma R, Sumadhura B, Kumar A, Datusalia AK


Recently, US Food and Drug Administration (FDA) has approved calcitonin gene-related peptide receptor antagonists (rimegepant, and ubrogepant), and selective serotonin receptor agonists (lasmiditan) in the management of migraine. However, the exact safety and efficacy profile of these drugs is unclear so far.